Prosecution Insights
Prosecution Insights
25 pending office actions • 14 art units • 22 examiners • 0 of 25 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 11 (44%) |
| §102 only | 2 (8%) |
| §112 only | 6 (24%) |
| Double-patenting only | 1 (4%) |
| No statute on record | 5 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELLMAN, KRISTINA M | 2 | 65.7% | +54.8% |
| BRADLEY, CHRISTINA | 2 | 62.8% | +33.2% |
| HA, JULIE | 2 | 75.6% | +44.2% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.6% |
| NAJARIAN, LENA | 1 | 38.8% | +39.1% |
| CHANDRA, GYAN | 1 | 71.1% | +27.6% |
| ANTHOPOLOS, PETER | 1 | 57.1% | +59.0% |
| SZPERKA, MICHAEL EDWARD | 1 | 62.6% | +37.0% |
| CARR, DEBORAH D | 1 | 81.7% | +2.6% |
| MEDWAY, SCOTT J | 1 | 67.1% | +23.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18274614 | NOVEL SYNTHESIS OF SALCAPROZIC ACID BY AMIDE FORMATION | CARR, DEBORAH D | 10d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18643038 | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | HELLMAN, KRISTINA M | 103d overdue |
| 18017041 | CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY | HA, JULIE | 28d overdue |
| 17598010 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | HA, JULIE | 28d overdue |
| 18242868 | FACTOR X BINDERS ENHANCING FX ACTIVATION | SZPERKA, MICHAEL EDWARD | 5d overdue |
| 18730933 | SYSTEMS AND METHODS FOR PERSONALIZED INSULIN TITRATION | NAJARIAN, LENA | 33d |
| 19460949 | COMPOSITIONS AND METHODS FOR PROGRAMMED DEATH LIGAND RECEPTOR (PD-L1) EXPRESSION | CHONG, KIMBERLY | — |
| 18426412 | GLP-1 RECEPTOR AGONISTS IN DEMENTIA | CHANDRA, GYAN | — |
| 18578485 | SODIUM N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLATE POLYMORPHIC FORM A | ANTHOPOLOS, PETER | — |
| Art Unit | Apps |
|---|---|
| 1654 | 6 |
| 3783 | 5 |
| 1674 | 2 |
| 1636 | 1 |
| 3687 | 1 |
| 1626 | 1 |
| 1641 | 1 |
| 1691 | 1 |
| 1615 | 1 |
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19460949 | COMPOSITIONS AND METHODS FOR PROGRAMMED DEATH LIGAND RECEPTOR (PD-L1) EXPRESSION | CHONG, KIMBERLY | 1636 | §103 | Non-Final OA | — | Pending | Jan 27, 2026 |
| 18730933 | SYSTEMS AND METHODS FOR PERSONALIZED INSULIN TITRATION | NAJARIAN, LENA | 3687 | §103 | Non-Final OA | 33d | Pending | Jul 22, 2024 |
| 18643038 | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | HELLMAN, KRISTINA M | 1654 | Other | Non-Final OA | 103d overdue | Pending | Apr 23, 2024 |
| 18426412 | GLP-1 RECEPTOR AGONISTS IN DEMENTIA | CHANDRA, GYAN | — | DP | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18578485 | SODIUM N-(8-(2- HYDROXYBENZOYL)AMINO)CAPRYLATE POLYMORPHIC FORM A | ANTHOPOLOS, PETER | 1626 | §103 | Non-Final OA | — | Pending | Jan 11, 2024 |
| 18242868 | FACTOR X BINDERS ENHANCING FX ACTIVATION | SZPERKA, MICHAEL EDWARD | 1641 | Other | Final Rejection | 5d overdue | Pending | Sep 06, 2023 |
| 18274614 | NOVEL SYNTHESIS OF SALCAPROZIC ACID BY AMIDE FORMATION | CARR, DEBORAH D | 1691 | §112 | Non-Final OA | 10d overdue | Pending | Jul 27, 2023 |
| 18271985 | A TORSION SPRING DRIVEN FIXED DOSE INJECTION DEVICE | MEDWAY, SCOTT J | 3783 | §102 | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18252056 | COMPOUNDS AND THEIR USE IN TREATMENT OF TACHYKININ RECEPTOR MEDIATED DISORDERS | BRADLEY, CHRISTINA | 1654 | §112 | Non-Final OA | — | Pending | May 08, 2023 |
| 18033572 | GLP-1, GIP AND GLUCAGON RECEPTOR TRIPLE AGONISTS | BRADLEY, CHRISTINA | 1654 | §103 | Non-Final OA | — | Pending | Apr 25, 2023 |
| 18020386 | INGESTIBLE DRUG DELIVERY DEVICE | GONZALEZ, LEI NMN | 3783 | §112 | Final Rejection | 26d | Pending | Feb 08, 2023 |
| 18017041 | CO-AGONISTS AT GLP-1 AND GIP RECEPTORS SUITABLE FOR ORAL DELIVERY | HA, JULIE | 1654 | §112 | Non-Final OA | 28d overdue | Pending | Jan 19, 2023 |
| 18015444 | METHODS FOR TREATING CARDIOVASCULAR DISEASE | HOWARD, ZACHARY C | 1674 | §112 | Final Rejection | 26d | Pending | Jan 10, 2023 |
| 17921996 | SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINE | TRAN, SUSAN T | 1615 | §103 | Non-Final OA | — | Pending | Oct 28, 2022 |
| 17800747 | GLP-1 COMPOSITIONS AND USES THEREOF | ATKINSON, JOSHUA ALEXANDER | 1612 | Other | Non-Final OA | 31d overdue | Pending | Aug 18, 2022 |
| 17833587 | METHODS FOR THE PURIFICATION OF PROTEINS USING CAPRYLIC ACID | BREEN, KIMBERLY CATHERINE | 1657 | §103 | Non-Final OA | 23d | Pending | Jun 06, 2022 |
| 17782249 | FIXED DOSE INJECTION DEVICE | GRASMEDER, SARAH DYMPNA | 3783 | §103 | Final Rejection | 11d overdue | Pending | Jun 03, 2022 |
| 17708660 | METHODS FOR TREATING IL-6 MEDIATED INFLAMMATION WITHOUT IMMUNOSUPPRESSION | CARTER, SANDRA DILLAHUNT | 1674 | §103 | Final Rejection | 34d | Pending | Mar 30, 2022 |
| 17638483 | PROCESS FOR PRODUCING A TABLET COMPRISING GLP-1 PEPTIDES | HELLMAN, KRISTINA M | 1654 | Other | Final Rejection | — | Pending | Feb 25, 2022 |
| 17598010 | GLUCOSE SENSITIVE INSULIN DERIVATIVES | HA, JULIE | 1654 | §102 | Non-Final OA | 28d overdue | Pending | Sep 24, 2021 |
| 17424537 | ROLLER COMPACTOR AND METHOD OF DRY GRANULATION USING A ROLLER COMPACTOR | ROGERS, JAMES WILLIAM | 1618 | §103 | Final Rejection | — | Pending | Jul 21, 2021 |
| 17418176 | DRUG RESERVOIR FOR SEPARATE STORAGE OF SUBSTANCES | DIPERT, FORREST BLAKE | 3783 | §103 | Final Rejection | 33d | Pending | Jun 24, 2021 |
| 17320436 | TABLET FORMULATION COMPRISING A GLP-1 PEPTIDE AND A DELIVERY AGENT | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | Other | Non-Final OA | — | Pending | May 14, 2021 |
| 17286639 | ZERO-POINT ADJUSTMENT OF PREFILLED DRUG DELIVERY DEVICE | ZAMORY, JUSTIN L | 3783 | §103 | Final Rejection | — | Pending | Apr 19, 2021 |
| 17270072 | SYSTEMS AND METHODS FOR PROVIDING CONTAINER BASED MEDICATION DOSE GUIDANCE TO TREAT DIABETES | ROSSI, VY BUI | 1685 | §112 | Final Rejection | 45d overdue | Pending | Feb 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial